Advanced HF/Transplant Cardiologist | SVP Medical Affairs, Edwards LifeSciences Implantable HF Management (IHFM)

Portland, OR
“H” White’s belief in the importance of giving back is an inspiration. I am honored to have played a role in his care and in the center which now bears his name. Thank you ⁦@HowardHWhite⁩ ⁦@Jumpman23⁩ ⁦ @Nike⁩ ⁦@Ludacris⁩ ⁦@christuckerreal⁩
7
6
50
5,067
Jacob Abraham, MD retweeted
This year we're building on the outstanding hemodynamic questions, providing practical learning for your cath lab, & a look to future innovation! PLUS - 2-day trainee program (Nov 13-14) on hemodynamics, engineering, & a TEACH session, @BurkhoffMd! @EdwardsLifesci @zoll_cms
Save the Date! 📅 The 2nd Annual Chicago Hemodynamic Forum will take place on Friday, November 14th, at UChicago 🫀 Registration is open NOW! uchicagohemodynamics.com #Cardiology #Cardiotwitter #HeartFailure #hearthealth #heartdisease
1
11
34
7,158
Jacob Abraham, MD retweeted
Congratulations to the ASCEND fellows! Thank you to the faculty who participated and shared their wisdom and experience over the last three programs. A special thanks to ⁦@shelleyhallmd⁩ ⁦@JeffTeuteberg⁩ and ⁦@AHajduczok⁩ for their passion and leadership! ⁦
2
5
15
1,416
Now out in @JCardFail: A prospective, multi-center registry of Impella 5.5 in HF-CS: 🔗bit.ly/4j8h171 🔑 Treatment with Impella 5.5 alone vs. multiple MCSD associated with ⬆️ survival and ⬇️complications 🔑 Patients bridged to HRT have 94% survival at 12- months
1
10
38
3,403
🔑 Patients bridged to recovery have low rates of heart replacement post-discharge and 12-month survival 64% "Bridging to recovery" encompasses palliative and therapeutic intent. Future trials need to capture intention of TMCS to place outcomes in context of goals.
1
2
8
713
Jacob Abraham, MD retweeted
The 1st annual Chicago Hemodynamic Forum was a success! Check out our special report in @CircHF reviewing the inaugural meeting ahajournals.org/doi/10.1161/… We're busy planning for year 2 - agenda coming shortly Save-the-date: Friday, November 14th in Chicago, IL! @ChiHForum
2
15
43
4,319
Jacob Abraham, MD retweeted
I mean seriously….who better to lead a system-wide, multidisciplinary effort around care coordination, delivery, & quality in the CS space than this guy 👇🏼👇🏼👇🏼?!! The answer: there is NO ONE BETTER! A win for @ISHVnews but an even bigger win for all who battle shock!
Excited to announce that CICU Medical Director, @ShashankSinhaMD has been named Director, Cardiogenic Shock, Inova Health System, and will lead system-wide multidisciplinary collaboration and care coordination among key stakeholders in the evaluation and management of Shock
5
9
74
7,989
Jacob Abraham, MD retweeted
🫀HF-related cardiogenic shock accounts for a growing proportion of CS related admissions to contemporary CICUs 🏥. New data published in @JCardFail from @CCCTNetwork compares patient characteristics, treatments, and outcomes between NICM and ICM in HF-CS
2
15
64
10,139
Jacob Abraham, MD retweeted
🎙 New Podcast Episode Released! 📖 Newly published in the @JCardFail and presented at #THT2025, a retrospective analysis using the Premier Healthcare Database (PHD), an all-payer database, demonstrated a large and significant reduction in hospital visits and length of stay in #Barostim patients with #heartfailure and reduced ejection fraction.1,2 Join @Abraham_Jacob, MD and Philip Adamson, MD as they provide their perspectives on this real-world evidence and its implications for heart failure management. Listen now: lnkd.in/gHhF35Hd ISI: barost.im/ISI 1. Abraham J, et al. Real-world analysis of healthcare utilization with baroreflex activation therapy for heart failure, JC ard Fail 2025 (online ahead of print). 2. Hospital length-of-stay was compared 12 months pre-implant and 12 ± 3 months post-implant; p<0.05 for length-of-stay
2
5
389
Jacob Abraham, MD retweeted
We wrapped up #THT2025 with an informative session on treating the dilated LV with the #AccuCinch System! Thank you to @UlrichJordeMD, @Reismanmmd, @BurkhoffMd, @dbufmd & @Abraham_Jacob for sharing your expertise and insights on the CORCINCH-HF #clinicaltrial. #cardioX #cardiotwitter @crfheart
2
2
308
Jacob Abraham, MD retweeted
👀 our takes on interesting papers in @TheJHLT not featured in past episodes. 👏 #CSWG for continuing to advance the field to win the #waronshock @NavinKapur4 @ElricZweck @lisong2003 @JHMontfort10 @Abraham_Jacob @ShashankSinhaMD @rachkataria @ReshadGaranMD
Replying to @TheJHLT
Studies include: - CMR to assess rejection and CAV in #Peds #HeartTx - A simulation framework for #OrganAllocation - The #HeartMate3 Snoopy for noninvasive cardiovascular diagnosis - Acute limb ischemia in #CardiogenicShock
1
5
9
1,930
Jacob Abraham, MD retweeted
Congrats to @Abraham_Jacob, MD, Meegan Mangum, PA and the research team at @ProvHealth on implanting the 1st Cordella™ PA Sensor on the West Coast as part of the PROACTIVE-HF-2 trial. Safety Info: endotronix.com/safety/ #PRO2 #clinicaltrial #heartfailure #cardiotwitter
3
5
682
More bad news for Advanced Heart Failure and Transplant Cardiology #NRMP match: Of 75 programs participating in match n=21 (28%) filled. Of 127 positions offered, n=61 (48%) filled. There will only be n=61 AHFTC trainees in the US in 2025-2026 academic year. #ShrinkingWorkforce
22
50
133
107,089
Jacob Abraham, MD retweeted
Limited data are available describing the distribution of the different hemodynamic PH subtypes amongst patients with heart failure using the current guidelines. We analyzed the Hemodynamic Frontiers in Heart Failure Registry, a multicenter database inclusive of consecutive adult patients implanted with an approved implantable hemodynamic sensor. kwnsfk27.r.eu-west-1.awstrac…
7
12
2,023
Jacob Abraham, MD retweeted
Bumetanide nasal spray safe, has equivalent pharmacodynamic efficacy (urine/sodium output) compared to IV and PO bumetanide administration. View slides here: clinicaltrialresults.org/wp-…
3
22
94
10,984